Trial intelligence / Profile preview

Phase 3 randomized double-blind study of upadacitinib monotherapy versus methotrexate monotherapy in methotrexate-naive moderate-to-severe rheumatoid arthritis

MOH_2017-04-19_000019Phase 3Active, not recruiting

Sponsor

AbbVie Inc.

Start

Feb 2016

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules

Countries

1